Montreal, January 7th, 2015 – CQDM is pleased to announce the publication of its 2014 Activity Report. Proud of the progress made in the last year, 2014 was the year of partnerships. In addition to welcoming Sanofi Canada into its consortium, CQDM extended its collaborations throughout Canada and globally. CQDM now has an outstanding portfolio of 35 projects carried out by…
Montreal, December 16th, 2014 – The Chairman of the Board, Mr. Léon Gosselin and the President and CEO of CQDM, Ms. Diane Gosselin are pleased to announce the appointment of Ms. Louise Proulx, Chief Development Officer at Therillia as a new member of CQDM’s Board of Directors, of Professor Hans Christian Fibiger, Associate Dean research at the Faculty of Medicine of…
Montreal, November 20th, 2014 – CQDM, Alsace BioValley and Lyonbiopôle launch the 5th competition of the Quebec/France Program to accelerate the discovery and development of new drugs. Once again this year, the goal of the joint program is to strengthen biomedical research in Quebec, Alsace and Rhône-Alpes by aligning scientific resources and expertise. More specifically, it is…
Michel Grenier, Executive Director, Centre d’entrepreneuriat, ESG UQAM, Mélissa Denis, Director, National and Sector Sales, Business Solutions, TC Media, Pierre Miron, Senior Vice-President, Operations and Information Technology, Caisse de dépôt et placement du Québec, Kathleen Zicat, Senior Vice-President, Particulier Québec, National Bank of Canada, Lise Bissonnette, Chair of the Board, UQAM, Robert Proulx, Rector, UQAM,…
Réseau ESG UQAM will salute the brilliant careers of seven graduates of UQAM’s École des sciences de la gestion (ESG UQAM) on November 18 at its annual Prix Performance Gala. Under the honorary chairmanship of Sylvain Roy (B.A.A. 91), President of Rogers Québec, the event will take place in the Salle Le Parquet at Centre…
Montreal, September 2, 2014. – The President and CEO of CQDM, Diane Gosselin, is pleased to announce the appointment of Mario Chevrette as Vice President, Scientific Affairs effective September 2, 2014. Mr. Chevrette will be responsible for all CQDM scientific affairs. More specifically, he will play a key role in managing funding programs and projects,…
Toxicity assessment by fluorescence and luminescencePhoto credit: Xiao-Yan Wen Toronto, August 19, 2014 – CQDM and Ontario Centres of Excellence (OCE) are pleased to announce the funding of a new collaborative, inter-provincial project that could accelerate clinical development of treatment for neurodegenerative diseases such as Alzheimer’s, Parkinson’s, Amyotrophic Lateral Sclerosis, and diabetes. As part of the Quebec-Ontario Life…
From left to right: Michele Davies, Director, Partnerships Development at OCE, Diane Gosselin, President and CEO at CQDM, Jacques Daoust, Quebec Minister of Economy, Innovation and Exports and John Clarkson, Senior Vice-President at OBI San Diego, June 23rd, 2014. – Ontario Centres of Excellence (OCE) and the Ontario Brain Institute (OBI) are partnering with CQDM to bring an additional $3 million to two programs…
San Diego, June 23, 2014. – The Ontario Centres of Excellence (OCE) and the Ontario Brain Institute (OBI) are partnering with CQDM to provide an additional $3 million to two programs focused on innovative technologies to accelerate drug discovery and development. With an investment of $500,000, the Ontario Centres of Excellence (OCE) are joining forces…
From left to right : Léon Gosselin, Chairman of CQDM’s Board of Directors; Marc Bonnefoi, the North America Head of R&D at Sanofi; Diane Gosselin, President and CEO of CQDM; Jon Fairest, President and CEO of Sanofi Canada and Franca Mancino, Sanofi Canada’s VP of Medical and Regulatory Affairs CQDM and Sanofi Canada are pleased to announce…